Zevra Therapeutics
ZVRA
ZVRA
70 hedge funds and large institutions have $98.1M invested in Zevra Therapeutics in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
14.37% more ownership
Funds ownership: 8.26% → 22.63% (+14%)
Holders
70
Holding in Top 10
–
Calls
$30.6M
Puts
$13.7M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$9.27M | |
| 3 | +$6.33M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$5.66M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.02M |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$1.66M | |
| 3 | -$1.47M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$794K |
| 5 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$615K |